Immix Biopharma Cash Flow Statement (2020-2026) | IMMX

Cash Flow Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-0.21M-0.40M-22.76M-1.33M-1.56M-1.54M-3.80M-2.50M-3.60M-4.34M-5.16M-5.33M-4.41M-7.15M15.30M-4.54M-6.62M-7.59M-10.69M-10.09M
Depreciation and Depletion (Quarter)
620.00620.00620.00620.00383.00566.00566.00505.00506.000.00M0.00M0.00M0.00M0.01M0.02M0.04M0.06M0.10M0.05M0.09M
Share-based Compensation (Quarter)
0.03M0.06M0.12M0.07M0.07M0.16M0.08M0.33M0.16M0.17M1.05M0.94M0.29M0.45M0.71M0.43M0.08M0.40M0.57M0.51M
Gains from Sales and Divestitures (Quarter)
0.02M0.31M0.43M0.39M0.34M0.25M0.18M0.11M0.04M
Gains from Investment Securities (Quarter)
1.76M0.00M1.19M1.77M1.77M0.01M1.77M0.74M2.51M0.01M4.00M0.02M1.57M4.09M0.02M0.02M5.26M-0.03M
Cash from Operations (Quarter)
-0.16M-0.05M-1.11M-1.49M-0.55M-1.46M-3.90M-2.09M-3.52M-3.09M-2.68M-3.83M-5.26M-4.04M-1.48M-1.69M-5.31M-5.91M-11.03M-9.83M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.04M0.04M0.04M
Depreciation & Amortization (CF) (Quarter)
620.00620.00620.00620.00383.00566.00566.00505.00506.000.00M0.00M0.00M0.00M0.01M0.02M0.04M0.06M0.10M0.05M0.09M
Change in Working Capital
Change in Accured Expenses (Quarter)
0.20M0.14M-0.08M0.16M-0.17M0.19M0.94M0.45M0.85M1.92M-1.80M2.00M2.28M0.26M0.52M1.04M-0.79M0.43M
Change in Taxes (Quarter)
0.03M0.02M-0.17M0.04M0.11M0.03M0.06M0.07M-0.02M0.38M0.47M0.91M-0.10M-0.07M0.22M-2.00M-0.02M-0.02M-0.01M725.00
Investing Activities
Capital Expenditures (Quarter)
0.01M0.30M0.10M0.27M0.51M0.07M0.13M0.37M0.17M0.03M
Change in Acquisitions & Divestments (Quarter)
3.00M
Cash from Investing Activities (Quarter)
-0.01M-0.30M-0.10M-0.27M-0.51M-0.07M-0.13M-0.37M-6.65M-4.80M
Financing Activities
Other financing activities (Quarter)
0.03M0.06M0.12M0.07M0.07M0.16M0.23M0.33M0.45M0.74M0.43M0.62M0.54M0.63M0.61M0.60M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
0.10M
Change in Capital Stock
Shares Issued (Quarter)
2.91M-2.44M0.10M-0.17M0.00M15.94M-15.94M15.94M516.00107.39M0.03M
Shares Repurchased (Quarter)
0.04M
Misc.
Cash from Financing Activities (Quarter)
0.08M-0.02M18.72M2.91M-0.11M0.42M0.12M4.69M10.07M0.59M15.95M10.61M95.67M-0.04M
Exchange Rate Effect (Quarter)
0.01M-0.00M621.00-0.00M-0.01M-0.02M-157.00-562.000.01M-0.01M0.03M-0.01M0.01M0.02M-0.03M-0.01M0.04M-0.02M-0.01M-0.01M
Change in Cash (Quarter)
-0.07M-0.07M17.61M1.42M-0.66M-1.49M-3.48M-1.97M1.19M6.93M-2.07M11.81M-5.34M-4.28M-2.01M-1.76M-4.28M4.31M77.98M-14.68M
Free Cash Flow (Quarter)
-0.16M-0.05M-1.11M-1.49M-0.55M-1.46M-3.90M-2.09M-3.52M-3.09M-2.69M-4.13M-5.35M-4.31M-1.98M-1.75M-5.44M-6.28M-11.19M-9.86M
Net Cash Flow (Quarter)
-0.08M-0.07M17.61M1.42M-0.65M-1.46M-3.48M-1.97M1.18M6.98M-2.10M11.82M-5.35M-4.31M-1.98M-1.75M-5.44M4.33M77.99M-14.67M